Search jobs Veterinary Imaging Market to Reach $2.65 Billion at 6.3% CAGR Globally by 2021 to 2026
Pune, Maharashtra, India, February 5 2021 (Wiredrelease) Allied Analytics –:”Veterinary Imaging Market by Product Type (Instrument, Reagents, and Others), Animal Type (Companion Animals, Large Animals, and Other Animals), Application (Orthopedics & Traumatology, Oncology, Cardiology, Neurology, and Other Application), and End User (Clinics & Hospitals, Reference Labs, and Other End User): Global Opportunity Analysis and Industry Forecast, 2019–2026.” According to the report, the global veterinary imaging industry garnered $1.62 billion in 2018, and is projected to reach $2.65 billion by 2026, registering a CAGR of 6.3% from 2019 to 2026.
Technological advancements in imaging systems, surge in pet ownership across the world, and increase in spending on animal health drive the growth of the global veterinary imaging market. However, lack of veter
LONDON, Jan. 20, 2021 /PRNewswire/ According to a new market research report, titled "In-vitro Diagnostics Market by Product & Solution (Consumables, Systems, Software & Services), Technology
by Product & Solution (Consumables, Systems, Software & Services), Technology (ELISA, Rapid Tests, PCR, Microbiology), Application (Infectious Diseases, Oncology), End User (Hospitals, Diagnostic Laboratories) Forecast to 2027 , published by Meticulous Research
®, the in-vitro diagnostics market is expected to register a CAGR of 7% from 2020 to 2027 to reach $118.5 billion by 2027.
The epidemiological burden of infectious diseases worldwide has increased in the past few years. During the past few decades, various infections such as severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), Ebola, chikungunya, avian flu, swine flu, and Zika have emerged as major threats to public health. The outbreak of the coronavirus (COVID-19) disease is a recent example. Although healthcare professionals are working tirelessly on the frontlines to fight the pandemic, it is equally important to minimize the spread of the disease by preparing kits for early diagnosis. Te
Managing Editor
Rite Aid is growing its COVID-19 testing footprint. The company said it would be opening 99 additional drive-thru sites offering no-charge COVID-19 tests on Dec. 22, which will bring its total testing footprint to 400 sites. With the expansion, Rite Aid will be offering testing in 12 states.
Camp Hill, Pa.-based Rite Aid said that like its other sites, the new locations will use self-swab nasal tests overseen by Rite Aid pharmacists. The sites will operate Monday through Friday from 10 a.m. to 8 p.m. and from 10 a.m. to 5 p.m. on Saturday and Sunday. The company said that its testing is available to anyone 14 years old and older, regardless of whether they are experiencing symptoms of the virus.